Insider Selling: Cognex (NASDAQ:CGNX) VP Sells 20,252 Shares of Stock

Cognex Corporation (NASDAQ:CGNXGet Free Report) VP Darren Marc Long sold 20,252 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the sale, the vice president owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. The trade was a 83.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Cognex Stock Performance

Shares of CGNX traded down $0.69 during midday trading on Thursday, hitting $66.01. 1,981,032 shares of the stock traded hands, compared to its average volume of 2,214,232. Cognex Corporation has a 1-year low of $29.22 and a 1-year high of $71.90. The firm has a market capitalization of $10.99 billion, a PE ratio of 78.58 and a beta of 1.48. The business’s 50 day moving average price is $56.33 and its two-hundred day moving average price is $47.21.

Cognex (NASDAQ:CGNXGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same quarter in the previous year, the company posted $0.14 earnings per share. The company’s revenue for the quarter was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, equities research analysts forecast that Cognex Corporation will post 1.4 EPS for the current fiscal year.

Cognex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st will be issued a dividend of $0.085 per share. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s payout ratio is 40.48%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CGNX. Weiss Ratings reissued a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. Citigroup reaffirmed a “neutral” rating and issued a $68.00 price objective (up from $60.00) on shares of Cognex in a report on Friday, May 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $63.00 price objective on shares of Cognex in a report on Friday, February 13th. Barclays reaffirmed an “overweight” rating and issued a $75.00 price objective (up from $64.00) on shares of Cognex in a report on Monday, May 11th. Finally, DA Davidson set a $62.00 price objective on shares of Cognex and gave the stock a “neutral” rating in a report on Thursday, May 14th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $70.43.

View Our Latest Research Report on Cognex

Institutional Investors Weigh In On Cognex

Hedge funds and other institutional investors have recently bought and sold shares of the business. REAP Financial Group LLC bought a new stake in Cognex in the third quarter worth about $27,000. Cassaday & Co Wealth Management LLC bought a new stake in Cognex in the first quarter worth about $36,000. CIBC Private Wealth Group LLC raised its position in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares in the last quarter. Geneos Wealth Management Inc. raised its holdings in Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares during the period. Finally, Smartleaf Asset Management LLC raised its holdings in Cognex by 207.6% during the 3rd quarter. Smartleaf Asset Management LLC now owns 935 shares of the scientific and technical instruments company’s stock worth $43,000 after buying an additional 631 shares during the period. 88.12% of the stock is currently owned by institutional investors.

Cognex Company Profile

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Further Reading

Insider Buying and Selling by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.